Skip to Content
  • Previous Rank50
  • Revenue 3 Yr Annual Growth Rate25%
  • Revenue 3 Yr Growth Rank66
  • EPS 3 Yr Annual Growth Rate54%
  • EPS 3 Yr Growth Rank31
  • Total Return 3 Yr Annual Rate-12%
  • Total Return 3 Yr Rank98
Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Information

Location
Tarrytown, N.Y.
Industry
Pharmaceuticals
Sector
Health Care
Current Streak2
Years on List2
CEO
Leonard Schleifer
Websitehttp://www.regeneron.com
Revenue and net income for the four quarters ended on or before April 30, 2018. Total return for the period ended June 29, 2018.

Revenue, Net Income

Revenue past four quarters ($M)$6,065
Net Income past four quarters ($M)$1,428

Growth Rates and Ranks

Revenue 3 Yr Growth Rank66
Revenue 3 Yr Annual Growth Rate25%
EPS 3 Yr Growth Rank31
EPS 3 Yr Annual Growth Rate54%
Total Return 3 Yr Rank98
Total Return 3 Yr Annual Rate-12%
Beat S&P 500 (11.9%)
no
P/E Ratio21